ÂÜÀòÂÒÂ×

The Research and Development team at Alcyone Therapeutics focuses on innovating and advancing gene therapy solutions for severe neurological conditions. This team, composed of scientists and engineers, collaborates to develop and optimize the company's proprietary CNS delivery technology, conduct preclinical research, and advance clinical programs targeting Rett syndrome and SMARD1. Their efforts are critical in transforming scientific breakthroughs into effective therapies that enhance patient outcomes in the central nervous system.